"Drug Design Novel Advances in the Omics Field and Applications" ed. by Arli Aditya Parikesit

This volume is dedicated to the studies of structural bioinformatics, pharmacogenomics, and metabolomics. These studies have enabled current accelerated effort in COVID-19 research, as well as other communicable and non-communicable diseases.

Right before the COVID-19 pandemic declared by the World Health Organization (WHO), life sciences have incited novel areas of studies that revolutionize the health sector. The structural bioinformatics field is the very foundation of drug design research, as it provides insight into the molecular simulations and interactions between the biomolecules and the drug candidates. Secondly, pharmacogenomics is the starting point of any efforts in developing personalized medicine. Lastly, metabolomics provides instrumentation to elicit biomarkers for various diseases and health conditions.


Contents
1. Introductory Chapter: The Emerging Corner of the Omics Studies for Rational Drug Design
2. Pharmacogenomics: Overview, Applications, and Recent Developments
3. Lipoproteomics: Methodologies and Analysis of Lipoprotein-Associated Proteins along with the Drug Intervention
4. Microarrays and NGS for Drug Discovery
5. The Rational Drug Design to Treat Cancers
6. Natural Medicinal Compounds from Marine Fungi towards Drug Discovery: A Review
7. Studies on Histamine H2-Receptor Antagonists by Using Density Functional Theory


More : You find here